Non-interventional open single arm, multicentre study to observe the use of Preotact [ALX-111] in patients with severe postmenopausal osteoporosis.

Trial Profile

Non-interventional open single arm, multicentre study to observe the use of Preotact [ALX-111] in patients with severe postmenopausal osteoporosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2013

At a glance

  • Drugs Parathyroid hormone (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms PROPOSE
  • Sponsors Takeda Pharmaceuticals International GmbH
  • Most Recent Events

    • 04 May 2012 Additional company (Takeda Global Research and Development Center) added in association as reported by ClinicalTrials.gov.
    • 22 Sep 2008 Actual patient number (110) added as reported by ClinicalTrials.gov.
    • 22 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top